Content reflects the views of the posting party and is provided for informational purposes only. It does not constitute a solicitation, recommendation, endorsement, or investment advice by BioTech Funding Portal.  All content is subject to the portal’s Community Content Guidelines.

 

 

Karin Hellsvik

Vice President, Head of IR & Comms; Strategic Advisor

Foghorn Therapeutics

Executive with 20+ years of experience and passion for improving patient care; building long-term value for biotech investors View (0) Answers

Eric Hanson

CEO

MILMED Connect

CEO of MILMED Connect. Dual-use life sciences tech. MD from Uniformed Services Univ. MPH epidemiology with genetics from Johns Hopkins. View (0) Answers

Madelyn De Los Santos

Senior Advisor

Putnam Insights LLC

Communications and strategic positioning professional at Putnam Insights supporting biotech, medtech, AI, and women’s health innovators. View (0) Answers

Robert Barich

Managing Director

CNR Search

25+ years in executive search, life sciences investing, and company-building to match leaders with business needs. View (0) Answers

Tetsu Yung

Director of JAPAC Strategy

Glafabra Therapeutics

Building JAPAC strategy for Glafabra to advance durable, cell-based therapy for Fabry disease patients View (0) Answers

Eydith Comenencia Ortiz

Founder

CONECTA

Executive with 15 years of experience advancing biotech innovation with evidence-based patient engagement & insights generation View (0) Answers

Want to see more? Login or Register for Free.